Article Information
History
- December 11, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- James Turnbull1,2,3,a,
- Rakesh Jha1,2,a,
- Catherine A. Ortori2,
- Eleanor Lunt4,
- Patrick J. Tighe3,
- William L. Irving1,3,
- Sameer A. Gohir1,6,
- Dong-Hyun Kim2,
- Ana M. Valdes1,5,6,
- Alexander W. Tarr1,3,
- David A. Barrett1,2 and
- Victoria Chapman1,3,5,*
- 1NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK
- 2Centre for Analytical Bioscience, Advanced Materials and Healthcare Technologies Division, School of Pharmacy, University of Nottingham, Nottingham, UK
- 3School of Life Sciences, Faculty of Medicine and Health Sciences, The University of Nottingham, Nottingham, UK
- 4Department of Health Care for Older People (HCOP), Queen’s Medical Centre, Nottingham University Hospitals NHS Trust, Derby Road, Nottingham, Nottinghamshire NG7 2UH, UK
- 5Pain Centre Versus Arthritis, University of Nottingham, Nottingham, UK
- 6Academic Rheumatology, University of Nottingham, Nottingham, UK
- ↵*Correspondence:
Professor Victoria Chapman, mbzvc{at}exmail.nottingham.ac.uk Phone: +44 (0)115 82 30136, School of Life Sciences, University of Nottingham, University Park, Nottingham, NG7 2RD
Posted December 11, 2021.
Serum levels of specialised pro-resolving molecule pathways are greatly increased in SARS-CoV-2 patients and correlate with markers of the adaptive immune response
